References
- Baliga, B. C. and S. Kumar. 2002. Role of Bcl-2 family of proteins in malignancy. Hematol. Oncol. 20: 63-74. https://doi.org/10.1002/hon.685
- Bhuiyan, M. M., Y. Li, S. Banerjee, F. Ahmed, Z. Wang, S. Ali, and F. H. Sarkar. 2006. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Res. 66: 10064-10072. https://doi.org/10.1158/0008-5472.CAN-06-2011
- Bracarda, S., O. de Cobelli, C. Greco, T. Prayer-Galetti, R. Valdagni, G. Gatta, F. de Braud, and G. Bartsch. 2005. Cancer of the prostate. Crit. Rev. Oncol. Hematol. 56: 379-396. https://doi.org/10.1016/j.critrevonc.2005.03.010
- Cosulich, S. C., P. J. Savory, and P. R. Clarke. 1999. Bcl-2 regulates amplification of caspase activation by cytochrome c. Curr. Biol. 9: 147-150. https://doi.org/10.1016/S0960-9822(99)80068-2
- Danial, N. N. and S. J. Korsmeyer. 2004. Cell death: Critical control points. Cell 116: 205-219. https://doi.org/10.1016/S0092-8674(04)00046-7
- Kang, J., D.-K. Lee, and C.-H. Lee. 2010. Cell cycle arrest and cytochrome c-mediated apoptotic induction in human lung cancer A549 cells by MCS-C2, an analogue of sangivamycin. J. Microbiol. Biotechnol. 20: 433-437.
- Kim, M. K., J. Min, B. Y. Choi, H. Lim, Y. H. Cho, and C.-H. Lee. 2007. Discovery of cyclin-dependent kinase inhibitor, CR229, using structure-based drug screening. J. Microbiol. Biotechnol. 17: 1712-1716.
- Lee, C.-H., H. Lim, S. Moon, C. Shin, S. Kim, B. J. Kim, and Y. Lim. 2007. Novel anticancer agent, benzyldihydroxyoctenone, isolated from Streptomyces sp. causes G1 cell cycle arrest and induces apoptosis of HeLa cells. Cancer Sci. 98: 795-802. https://doi.org/10.1111/j.1349-7006.2007.00473.x
- Lieberman, R. 2004. Evidence-based medical perspectives: The evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer. Am. J. Ther. 11: 501-506. https://doi.org/10.1097/01.mjt.0000141604.20320.0c
- Lim, H., Y. Lim, Y. H. Cho, and C.-H. Lee. 2006. Induction of apoptosis in the HepG2 cells by HY53, a novel natural compound isolated from Bauhinia forficate. J. Microbiol. Biotechnol. 16: 1262-1268.
- Lim, H., H. L. Oh, and C.-H. Lee. 2006. Effects of Aralia continentalis root extract on cell proliferation and apoptosis in human promyelocytic leukemia HL-60 cells. J. Microbiol. Biotechnol. 16: 1399-1404.
- Moon, H. S., H. Lim, S. Moon, H. L. Oh, Y. T. Kim, M. K. Kim, and C.-H. Lee. 2009. Benzyldihydroxyoctenone, a novel anticancer agent, induces apoptosis via mitochondrial-mediated pathway in androgen-sensitive LNCaP prostate cancer cells. Bioorg. Med. Chem. Lett. 19: 742-744. https://doi.org/10.1016/j.bmcl.2008.12.029
- Nunez, G., M. A. Benedict, Y. Hu, and N. Inohara. 1998. Caspases: The proteases of the apoptotic pathway. Oncogene 17: 3237-3245.
- Oh, H. L., D. K. Lee, H. Lim, and C.-H. Lee. 2010. HY253, a novel decahydrofluorene analog, from Aralia continentalis, induces cell cycle arrest at the G1 phase and cytochrome cmediated apoptosis in human lung cancer A549 cells. J. Ethnopharmacol. 129: 135-139. https://doi.org/10.1016/j.jep.2010.02.010
- Oh, H. L., H. Lim, Y. H. Cho, H. C. Koh, H. Kim, Y. Lim, and C.-H. Lee. 2009. HY251, a novel cell cycle inhibitor isolated from Aralia continentalis, induces G1 phase arrest via p53- dependent pathway in HeLa cells. Bioorg. Med. Chem. Lett. 19: 959-961. https://doi.org/10.1016/j.bmcl.2008.11.087
- Oh, H. L., H. Lim, Y. Park, Y. Lim, H. C. Koh, Y. H. Cho, and C.-H. Lee. 2009. HY253, a novel compound isolated from Aralia continentalis, induces apoptosis via cytochrome c-mediated intrinsic pathway in HeLa cells. Bioorg. Med. Chem. Lett. 19: 797-799. https://doi.org/10.1016/j.bmcl.2008.12.009
- Sheikh, M. S. and A. J. Jr. Fornace. 2000. Role of p53 family members in apoptosis. J. Cell Physiol. 182: 171-181. https://doi.org/10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3
- Sramkoski, R. M., T. G. Pretlow II, J. M. Giaconia, T. P. Pretlow, S. Schwartz, M. S. Sy, et al. 1999. A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell. Dev. Biol. Animu. 35: 403-409. https://doi.org/10.1007/s11626-999-0115-4
- Strasser, A., L. O'Connor, and V. M. Dixit. 2000. Apoptosis signaling. Ann. Rev. Biochem. 69: 217-245. https://doi.org/10.1146/annurev.biochem.69.1.217
- Thalmann, G. N., P. E. Anezinis, S. M. Chang, H. E. Zhau, E. E. Kim, V. L. Hopwood, S. Pathak, A. C. von Eschenbach, and L. W. Chung. 1994. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res. 54: 2577-2581.
- Thalmann, G. N., R. A. Sikes, T. T. Wu, A. Degeorges, S. M. Chang, M. Ozen, S. Pathak, and L. W. Chung. 2000. LNCaP progression model of human prostate cancer: Androgenindependence and osseous metastasis. Prostate 44: 91-103. https://doi.org/10.1002/1097-0045(20000701)44:2<91::AID-PROS1>3.0.CO;2-L
- Verhaegh, M. E., C. J. Sanders, J. W. Arends, and H. A. Neumann. 1995. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer. Br. J. Dermatol. 132: 740-744.
- Yunis, J. J., G. Frizzera, M. M. Oken, J. McKenna, A. Theologides, and M. Arnesen. 1987. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N. Engl. J. Med. 316: 79-84. https://doi.org/10.1056/NEJM198701083160204
- Zeuthen, J., J. O. Norqaard, P. Avener, M. Fellous, J. Wartiovaara, A. Vaheri, A. Rosen, and B. C. Giovanella. 1980. Characterization of a human ovarian teratocarcinoma-derived cell line. Int. J. Cancer 25: 19-32. https://doi.org/10.1002/ijc.2910250104
Cited by
- Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer vol.143, pp.3, 2011, https://doi.org/10.1002/ijc.31346